CHLOE LINTON: Open Payments
NPI 1407510563 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 32 payments from 15 companies in 2025. Trend: 2023 $438 · 2024 $563 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $135 |
| Janssen Biotech, Inc. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| PFIZER INC. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Melinta Therapeutics, LLC | 2 | $46 |
| Incyte Corporation | 2 | $42 |
| Alexion Pharmaceuticals, Inc. | 2 | $38 |
| Stryker Corporation | 1 | $30 |
| Legend Biotech USA Inc. | 1 | $24 |
Products named: KEYTRUDA, DARZALEX, XIFAXAN, JARDIANCE, Rezzayo, IBRANCE, JAKAFI, ULTOMIRIS.
Industry payments across NC — which companies pay providers there.
